Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Jonas

Showing results (311-320 of 342) with videos related to

Pageof 35
Sort By:
Transplantation Proceedings|September 2, 1998
Impact of noninvasive diagnostic methods on the incidence and prognosis of cardiac allograft rejectionO Grauhan, C Knosalla, J Müller, et al.
Transplantation Proceedings|April 6, 2005
Grafts from elderly donors elicit a stronger immune response in the early period posttransplantation: a study in a rat modelA Reutzel-Selke, A Filatenkov, A Jurisch, et al.
Transplantation Proceedings|February 1, 1995
Factors relevant to the development of primary dysfunction in liver allograftsG W Haller, J M Langrehr, G Blumhardt, et al.
Transplantation Proceedings|December 1, 1996
Posttransplant malignancy and newer immunosuppressive protocols after liver transplantationS Jonas, W O Bechstein, N Rayes, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 1997
The status of p53 in the metastatic progression of colorectal cancerI Heide, C Thiede, T Sonntag, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|October 18, 2005
Magnetic resonance imaging including magnetic resonance cholangiopancreatography for tumor localization and therapy planning in malignant hilar obstructionsE L Hänninen, M Pech, S Jonas, et al.
Transplantation Proceedings|September 25, 2002
Early cellular markers for the prediction of chronic graft deterioration in a retransplantation modelS G Tullius, U Bachmann, C Heidenhain, et al.
Transplantation Proceedings|June 24, 1998
Comparison of quadruple induction including ATG or IL-2R antibody with FK506-based therapy after liver transplantationJ M Langrehr, A Schneller, O Guckelberger, et al.
Transplantation Proceedings|August 15, 2002
Sirolimus inhibits growth of human hepatoma cells in contrast to tacrolimus which promotes cell growthG Schumacher, M Oidtmann, S Rosewicz, et al.
Clinical Transplantation|December 31, 1997
Prophylactic use of low-dose urodilatin for prevention of renal impairment following liver transplantation: a randomized placebo-controlled studyJ M Langrehr, A Kahl, M Meyer, et al.
Pageof 35

Showing results (311-320 of 342) with videos related to

Sort By:
Pageof 35
Transplantation Proceedings|September 2, 1998
Impact of noninvasive diagnostic methods on the incidence and prognosis of cardiac allograft rejectionO Grauhan, C Knosalla, J Müller, et al.
Transplantation Proceedings|April 6, 2005
Grafts from elderly donors elicit a stronger immune response in the early period posttransplantation: a study in a rat modelA Reutzel-Selke, A Filatenkov, A Jurisch, et al.
Transplantation Proceedings|February 1, 1995
Factors relevant to the development of primary dysfunction in liver allograftsG W Haller, J M Langrehr, G Blumhardt, et al.
Transplantation Proceedings|December 1, 1996
Posttransplant malignancy and newer immunosuppressive protocols after liver transplantationS Jonas, W O Bechstein, N Rayes, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 1997
The status of p53 in the metastatic progression of colorectal cancerI Heide, C Thiede, T Sonntag, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|October 18, 2005
Magnetic resonance imaging including magnetic resonance cholangiopancreatography for tumor localization and therapy planning in malignant hilar obstructionsE L Hänninen, M Pech, S Jonas, et al.
Transplantation Proceedings|September 25, 2002
Early cellular markers for the prediction of chronic graft deterioration in a retransplantation modelS G Tullius, U Bachmann, C Heidenhain, et al.
Transplantation Proceedings|June 24, 1998
Comparison of quadruple induction including ATG or IL-2R antibody with FK506-based therapy after liver transplantationJ M Langrehr, A Schneller, O Guckelberger, et al.
Transplantation Proceedings|August 15, 2002
Sirolimus inhibits growth of human hepatoma cells in contrast to tacrolimus which promotes cell growthG Schumacher, M Oidtmann, S Rosewicz, et al.
Clinical Transplantation|December 31, 1997
Prophylactic use of low-dose urodilatin for prevention of renal impairment following liver transplantation: a randomized placebo-controlled studyJ M Langrehr, A Kahl, M Meyer, et al.
Pageof 35